[Mullerian adenosarcoma of the cervix: case report with conservative management].

Cir Cir

Consultorio de Patología Dra. Isabel Ruiz Juárez, Veracruz. Ver. México.

Published: January 2019

Background: Mullerian adenosarcoma is a rare gynecological malignancy with a low malignant potential, with biphasic growth, consisting of a benign epithelial element and a malignant mesenchymal element. It occurs in all ages predominating in postmenopausal women. Cervical localization of Mullerian adenosarcomas is rare; however, it is associated with a presentation in young women. The diagnosis is made by anatomopathological study of the lesion and immunohistochemistry. The prognosis is generally good although the recurrence rate is high.

Clinical Case: We present the case of a 27-year-old patient who attended a gynecological consultation with bleeding and transvaginal flow. During the gynecological examination, a polypoid lesion originating in the cervix was identified, which was removed by torsion and was diagnosed as Mullerian cervical adenosarcoma. Subsequently, a cervical cone was performed because the patient refused hysterectomy.

Conclusions: Mullerian cervical adenosarcoma is a rare neoplasm with a recurrence rate that can reach up to 50% of cases, so close follow-up is necessary. A local excision can be considered in patients without poor prognosis factors and who wish to preserve their fertility.

Download full-text PDF

Source
http://dx.doi.org/10.24875/CIRU.M18000027DOI Listing

Publication Analysis

Top Keywords

adenosarcoma rare
8
recurrence rate
8
mullerian cervical
8
cervical adenosarcoma
8
[mullerian adenosarcoma
4
adenosarcoma cervix
4
cervix case
4
case report
4
report conservative
4
conservative management]
4

Similar Publications

Uterine adenosarcoma coexisting with endometrial carcinoma is a very rare disease. Herein, we reported the case of uterine adenosarcoma coexisting with endometrioid endometrial carcinoma. Transvaginal ultrasound, computed tomography, and magnetic resonance imaging examinations all indicated a space-occupying lesion in the uterine cavity, and initially was considered endometrial carcinoma.

View Article and Find Full Text PDF

Introduction: Uterine adenosarcoma (UA) is a rare malignant mesenchymal neoplasm characterized by benign epithelial and malignant stromal components. Comprehensive genomic profiling has identified a high frequency of murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification in UA. However, the significance of these genetic alterations in tumor biology remains poorly understood.

View Article and Find Full Text PDF

Mullerian adenosarcoma is rare, usually found in the uterine corpus and rarely in the cervix. Adenosarcoma that grows diffusely in the uterine cavity and the cervical canal is even rarer without symptoms. Herein, we report a rare case of multiple primary malignant neoplasms of Mullerian adenosarcoma accidentally detected and coexisting with cervical carcinoma .

View Article and Find Full Text PDF

Application of Hysteroscopy in the Treatment of Mullerian Adenosarcoma of the Cervix in an Adolescent Girl with 7 Years of Follow-up.

J Pediatr Adolesc Gynecol

October 2024

Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, People's Republic of China. Electronic address:

Article Synopsis
  • Mullerian adenosarcoma of the cervix is a rare tumor with both benign and malignant components, highlighted through a case study of a 16-year-old girl treated successfully.
  • The patient experienced rapid growth of a vaginal mass that led to its spontaneous expulsion, confirmed as Mullerian adenosarcoma after examination.
  • A fertility-preserving treatment involving hysteroscopic resection was performed, and the patient has remained tumor-free after nearly 7 years of follow-up, suggesting effective management for young women with this condition.
View Article and Find Full Text PDF

Survival Trends for Uterine Sarcomas from a Tertiary Center: The Oxford Experience.

Diseases

September 2024

Department of Gynaecological Oncology, Churchill Hospital, Oxford University Hospitals, NHS Foundation Trust, Oxford OX3 7LE, UK.

Uterine sarcomas are rare and aggressive gynecological malignancies. We evaluated the epidemiology, treatment outcomes and survival rates in uterine sarcoma patients managed in our institute. The medical records of women with histology proven uterine sarcoma, including leiomyosarcoma (LMS), adenosarcoma (ADS), and endometrial stromal sarcoma (ESS), treated at our institution from February 2010 to February 2022, were analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!